EVENT
WPI-Bio2Q Kickoff Symposium
February 3, 2023

Lecture by Professor Kenya Honda, Bio2Q center director
Credits: Susumu Ishito

Lecture by Professor Makoto Arita, Bio2Q core director
Credits: Susumu Ishito

Lecture by Professor Yasuyo Minagawa, principal investigator
Credits: Susumu Ishito

Lecture by Senior Assistant Professor Oltea Sampetrean, administrative director
Credits: Susumu Ishito

Lecture by Professor Radu Aricescu, principal investigator (MRC Molecular Biology Laboratory programme leader, UK)
Credits: Susumu Ishito

Lecture by Project Lecturer Hideaki Kawaguchi, junior principal investigator
Credits: Susumu Ishito

Discussion with Professor Michisuke Yuzaki, special advisor to the director of Bio2Q, and Professor George Augustine, principal investigator (Nanyang Technological University School of Medicine, Singapore)
Credits: Susumu Ishito

Inside the event venue
Credits: Susumu Ishito

WPI Program Director Akira Ukawa and Bio2Q researchers who attended the event in person
Credits: Susumu Ishito


















On Friday, February 3, the Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) held its first symposium at Shinanomachi Campus.
This symposium was an event where Bio2Q researchers shared their work with those both inside and outside the center and discussed potential future avenues in science. The hybrid event was held online and in-person and broadcast live to the world.
Akira Ukawa, program director of the World Premier International Research Center Initiative (WPI), opened the event by introducing Bio2Q’s place in WPI. This was followed by sessions with nine of the world’s top scientists from the U.S., Europe, and Asia that work with Bio2Q. The sessions included introductions of each scientist’s specialty as well as dedicated time for Q&As.
About 200 participants joined the symposium, including more than 40 from outside Keio University from the Philippines, the U.K., and the U.S. They engaged in lively discussions about how to achieve good health and longevity in society through the integration of human biology, microflora, and quantum computing, as well as about future developments of new life sciences.
Bio2Q is the first microbiome research center in Japan, and the first private university to be selected by MEXT as a WPI. It will use both quantum computing and conventional bioanalytical methods to reveal the complex interactions between the microbiome and humans at the molecular level. In the future, the center hopes to develop new medications and therapies for diseases that have proven difficult to treat.
*Masks were only removed during speeches and briefly for the purpose of taking commemorative photos.
More Bio2Q News
Newsletter "Bio2Q Connect" (Vol. 2, Issue 4)
We are delighted to share with you Vol. 2, Issue 4 of WPI-Bio2Q Newsletter "Bio2Q Connect". Major topics of this issue include: New ...
[Seminar] WPI-Bio2Q Open Seminar: Wataru Shihoya, Ph.D.(for Keio Members)
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This is an event only for facul...
The 3rd Keio University WPI-Bio2Q International Symposium [Updated on Jan. 27]
The Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold the 3rd Keio University WPI-Bio2Q International S...
[Publication] Advantages of Fixing Spins in Quantum Annealing
Title Advantages of Fixing Spins in Quantum Annealing Authors Tomohiro Hattori [1]; Hirotaka Irie [2]; Tadashi Kadowaki [2],[3]; and ...
[Publication] Characterization of UGT8 as a monogalactosyl diacylglycerol syntha...
Title Characterization of UGT8 as a monogalactosyl diacylglycerol synthase in mammals Authors Yohsuke Ohba [1],[2]; Mizuki Motohashi...